Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis

Yuanyuan Xu, Zhixuan Li, Shuwei Wu, Linghong Guo, Xian Jiang

Open source

DOI
10.3389/fimmu.2023.1180170
Published
2023-06-02
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1180170,
  title = {Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis},
  author = {Yuanyuan Xu and Zhixuan Li and Shuwei Wu and Linghong Guo and Xian Jiang},
  year = {2023},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2023.1180170},
  url = {https://doi.org/10.3389/fimmu.2023.1180170}
}

RIS

TY  - JOUR
TI  - Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis
AU  - Yuanyuan Xu
AU  - Zhixuan Li
AU  - Shuwei Wu
AU  - Linghong Guo
AU  - Xian Jiang
PY  - 2023
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2023.1180170
UR  - https://doi.org/10.3389/fimmu.2023.1180170
ER  - 

APA

Xu, Y., Li, Z., Wu, S., Guo, L., & Jiang, X. (2023). Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1180170

Source records